The 3rd Annual Pharma Commercial Excellence Summit is a senior-level industry forum taking place on 25–26 March 2026 in Madrid, bringing together C-level executives, senior vice presidents, and commercial leaders from leading pharmaceutical organisations to focus on practical commercial transformation and measurable impact. The 2026 edition centres on the transition from digital adoption to AI-enabled commercial decision-making, addressing how artificial intelligence, analytics, CRM, automation, and omnichannel capabilities are embedded into go-to-market models to improve execution speed, simplify operational complexity, strengthen data governance and compliance, and drive sustainable enterprise value. Through real-world case studies and peer-level discussions, the summit explores AI-driven launch excellence, commercial process automation, portfolio and field force optimisation, customer engagement strategy, and the redesign of commercial operating models, leadership, and capabilities in AI-enabled organisations.
Topics: Pharma commercial excellence, AI in pharmaceuticals, Go-to-Market strategy, Commercial transformation, CRM optimisation, Omnichannel engagement, Sales force effectiveness, Launch excellence, Customer experience, Data governance and compliance, Commercial operations, Process automation, Field force optimisation, Business insights and analytics, Leadership in AI-enabled organisations